Intellia Therapeutics, Inc. (NTLA)
13.67
+0.58
(+4.43%)
USD |
NASDAQ |
May 15, 16:00
13.50
-0.17
(-1.24%)
After-Hours: 20:00
Intellia Therapeutics Total Assets (Quarterly) : 758.78M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.340B |
| KalVista Pharmaceuticals, Inc. | 328.92M |
| Beam Therapeutics, Inc. | 1.481B |
| Novavax, Inc. | 1.043B |
| Regeneron Pharmaceuticals, Inc. | 40.87B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 137.84M |
| Shareholders Equity (Quarterly) | 620.94M |
| Debt to Equity Ratio | 0.1296 |
| Current Ratio | 6.102 |
| Net Debt Paydown Yield | 1.68% |